Basic Body Awareness Therapy in Individuals With Migraine
NCT ID: NCT07328685
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2026-01-02
2026-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Head Awareness in Chronic Migraine Patients
NCT06857383
"Personalized Physiotherapy for Migraine: Effects on Pain, Fatigue, and Physical Function"
NCT07261384
The Effect of Body Awareness on Pain, Disability, Sensorimotor Acuity, Psychosocial and Central Sensitization Levels in Individuals With Non-Specific Chronic Low Back Pain
NCT07296185
Coping Skills for Migraine: A 6-Month Program
NCT07163559
Evaluation of a Mind-Body Based Approach for Chronic Pain Treatment
NCT07143396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Body Awareness Therapy Plus Standard Treatment
Participants in this group will receive body awareness therapy in addition to standard treatment. The exercise program will be implemented twice over an eight-week period.
Exercise
Participants will receive body awareness therapy. The program will be administered over an eight-week period and will include exercises appropriate for the study population.
Standart therapy
Standard treatment will be in the form of individual information sessions lasting approximately 30 minutes for both groups. Brochures will be created for distribution to individuals.
Standart Treatment
Participants in this group will receive standard treatment without the additional body awareness therapy.
Standart therapy
Standard treatment will be in the form of individual information sessions lasting approximately 30 minutes for both groups. Brochures will be created for distribution to individuals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Participants will receive body awareness therapy. The program will be administered over an eight-week period and will include exercises appropriate for the study population.
Standart therapy
Standard treatment will be in the form of individual information sessions lasting approximately 30 minutes for both groups. Brochures will be created for distribution to individuals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experiencing at least 3 migraine attacks per month,
* Between the ages of 18 and 55 and who volunteer to participate in the study.
Exclusion Criteria
* Being pregnant,
* Having any other neurological disease besides migraine,
* Having other secondary headaches in addition to migraine,
* History of malignancy,
* Regularly practicing meditation, yoga, or mindfulness-based practices.
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mustafa Kemal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasemin KARAASLAN
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMKU-BBAT-2026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.